Minimally invasive surgical therapies for benign prostatic hypertrophy: The rise in minimally invasive surgical therapies
The prevalence of benign prostatic hypertrophy (BPH) causing bothersome lower urinary tract symptoms increases with our ageing population. Treatment of BPH traditionally begins with medical therapy and surgical intervention is then considered for those whose symptoms progress despite treatment. Mini...
Main Authors: | Daniel Christidis, Shannon McGrath, Marlon Perera, Todd Manning, Damien Bolton, Nathan Lawrentschuk |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Prostate International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2287888217300016 |
Similar Items
-
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm3 and 80–150-cm3 Prostates
by: David-Dan Nguyen, et al.
Published: (2021-03-01) -
Pharmacological and interventional treatment of benign prostatic obstruction: An evidence‐based comparative review
by: Sachin Malde, et al.
Published: (2021-07-01) -
Current surgical procedures for benign prostatic hyperplasia and impression of new surgical modalities
by: Abdullah M Al Khayal, et al.
Published: (2021-01-01) -
Modern approaches to surgical and minimally invasive treatment of patients with benign prostate hyperplasia
by: A. A. Zimichev, et al.
Published: (2020-12-01) -
An Update on Minimally Invasive Surgery for Benign Prostatic Hyperplasia: Techniques, Risks, and Efficacy
by: Aditya Srinivasan, et al.
Published: (2020-10-01)